71 related articles for article (PubMed ID: 31725651)
21. Subclinical Hypothyroidism and Low-Normal Thyroid Function Are Associated With Nonalcoholic Steatohepatitis and Fibrosis.
Kim D; Kim W; Joo SK; Bae JM; Kim JH; Ahmed A
Clin Gastroenterol Hepatol; 2018 Jan; 16(1):123-131.e1. PubMed ID: 28823829
[TBL] [Abstract][Full Text] [Related]
22. Thyroid function is associated with non-alcoholic fatty liver disease in chronic hepatitis B-infected subjects.
Ding WJ; Wang MM; Wang GS; Shen F; Qin JJ; Fan JG
J Gastroenterol Hepatol; 2015 Dec; 30(12):1753-8. PubMed ID: 25974331
[TBL] [Abstract][Full Text] [Related]
23. Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients.
Huang Y; Gan Q; Lai R; Wang W; Guo S; Sheng Z; Chen L; Guo Q; Cai W; Wang H; Zhao G; Cao Z; Xie Q
Front Cell Infect Microbiol; 2021; 11():733348. PubMed ID: 35111690
[TBL] [Abstract][Full Text] [Related]
24. Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?
Carulli L; Ballestri S; Lonardo A; Lami F; Violi E; Losi L; Bonilauri L; Verrone AM; Odoardi MR; Scaglioni F; Bertolotti M; Loria P
Intern Emerg Med; 2013 Jun; 8(4):297-305. PubMed ID: 21559749
[TBL] [Abstract][Full Text] [Related]
25. PNPLA3 polymorphism influences the association between high-normal TSH level and NASH in euthyroid adults with biopsy-proven NAFLD.
Hu DS; Zhu SH; Liu WY; Pan XY; Zhu PW; Li YY; Zheng KI; Ma HL; You J; Targher G; Byrne CD; Chen YP; Zheng MH
Diabetes Metab; 2020 Nov; 46(6):496-503. PubMed ID: 32035968
[TBL] [Abstract][Full Text] [Related]
26. Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity?
Lonardo A; Ballestri S; Mantovani A; Nascimbeni F; Lugari S; Targher G
Dig Liver Dis; 2019 Apr; 51(4):462-470. PubMed ID: 30733187
[TBL] [Abstract][Full Text] [Related]
27. Association of non-alcoholic fatty liver disease with thyroid function: A systematic review and meta-analysis.
Guo Z; Li M; Han B; Qi X
Dig Liver Dis; 2018 Nov; 50(11):1153-1162. PubMed ID: 30224316
[TBL] [Abstract][Full Text] [Related]
28. Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Mantovani A; Nascimbeni F; Lonardo A; Zoppini G; Bonora E; Mantzoros CS; Targher G
Thyroid; 2018 Oct; 28(10):1270-1284. PubMed ID: 30084737
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of NAFLD development and therapeutic strategies.
Friedman SL; Neuschwander-Tetri BA; Rinella M; Sanyal AJ
Nat Med; 2018 Jul; 24(7):908-922. PubMed ID: 29967350
[TBL] [Abstract][Full Text] [Related]
30. Low-Dose Levothyroxine Reduces Intrahepatic Lipid Content in Patients With Type 2 Diabetes Mellitus and NAFLD.
Bruinstroop E; Dalan R; Cao Y; Bee YM; Chandran K; Cho LW; Soh SB; Teo EK; Toh SA; Leow MKS; Sinha RA; Sadananthan SA; Michael N; Stapleton HM; Leung C; Angus PW; Patel SK; Burrell LM; Lim SC; Sum CF; Velan SS; Yen PM
J Clin Endocrinol Metab; 2018 Jul; 103(7):2698-2706. PubMed ID: 29718334
[TBL] [Abstract][Full Text] [Related]
31. Relationship between Hypothyroidism and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
He W; An X; Li L; Shao X; Li Q; Yao Q; Zhang JA
Front Endocrinol (Lausanne); 2017; 8():335. PubMed ID: 29238323
[TBL] [Abstract][Full Text] [Related]
32. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.
Younossi Z; Anstee QM; Marietti M; Hardy T; Henry L; Eslam M; George J; Bugianesi E
Nat Rev Gastroenterol Hepatol; 2018 Jan; 15(1):11-20. PubMed ID: 28930295
[TBL] [Abstract][Full Text] [Related]
33. Nonalcoholic Fatty Liver Disease Is Not Associated with Thyroid Hormone Levels and Hypothyroidism: A Systematic Review and Meta-Analysis.
Jaruvongvanich V; Sanguankeo A; Upala S
Eur Thyroid J; 2017 Jul; 6(4):208-215. PubMed ID: 28868261
[TBL] [Abstract][Full Text] [Related]
34. Hypothyroidism Induces a Moderate Steatohepatitis Accompanied by Liver Regeneration, Mast Cells Infiltration, and Changes in the Expression of the Farnesoid X Receptor.
Rodríguez-Castelán J; Corona-Pérez A; Nicolás-Toledo L; Martínez-Gómez M; Castelán F; Cuevas-Romero E
Exp Clin Endocrinol Diabetes; 2017 Mar; 125(3):183-190. PubMed ID: 27701715
[TBL] [Abstract][Full Text] [Related]
35. Nonalcoholic fatty liver disease in Asia: emerging perspectives.
Seto WK; Yuen MF
J Gastroenterol; 2017 Feb; 52(2):164-174. PubMed ID: 27637587
[TBL] [Abstract][Full Text] [Related]
36. Thyroid Function and the Risk of Nonalcoholic Fatty Liver Disease: The Rotterdam Study.
Bano A; Chaker L; Plompen EP; Hofman A; Dehghan A; Franco OH; Janssen HL; Darwish Murad S; Peeters RP
J Clin Endocrinol Metab; 2016 Aug; 101(8):3204-11. PubMed ID: 27270473
[TBL] [Abstract][Full Text] [Related]
37. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Younossi ZM; Koenig AB; Abdelatif D; Fazel Y; Henry L; Wymer M
Hepatology; 2016 Jul; 64(1):73-84. PubMed ID: 26707365
[TBL] [Abstract][Full Text] [Related]
38. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.
Schweitzer A; Horn J; Mikolajczyk RT; Krause G; Ott JJ
Lancet; 2015 Oct; 386(10003):1546-55. PubMed ID: 26231459
[TBL] [Abstract][Full Text] [Related]
39. Low-normal thyroid function and the pathogenesis of common cardio-metabolic disorders.
van Tienhoven-Wind LJ; Dullaart RP
Eur J Clin Invest; 2015 May; 45(5):494-503. PubMed ID: 25690560
[TBL] [Abstract][Full Text] [Related]
40. The global burden of liver disease: the major impact of China.
Wang FS; Fan JG; Zhang Z; Gao B; Wang HY
Hepatology; 2014 Dec; 60(6):2099-108. PubMed ID: 25164003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
